Cytomegalovirus Antibodies IgM, CMV IgM (Serum)
The study is designed to detect IgM class antibodies to cytomegalovirus (CMV).
Used for diagnosing primary infection or virus reactivation.
Particularly important when examining pregnant women, as primary CMV infection during pregnancy can lead to intrauterine fetal infection.
Prescribed for patients with weakened immunity to assess infection activity and the need for antiviral therapy.
Helps the physician determine pregnancy management tactics, preventive measures, and therapy monitoring in immunosuppressed patients.
What the test assesses:
– Presence of IgM antibodies to CMV in serum.
– Active phase of the infectious process.
– Ability to distinguish fresh infection or virus reactivation from past infection (characterized only by IgG).
Biomaterial: Venous blood (serum)
– Submit fasting.
– Avoid alcohol consumption and intense physical exertion for 24 hours before the test.
– Optimal to submit the test in the morning for indicator stability.
Medications:
– As prescribed by a doctor.
– Inform your doctor about all medications and supplements taken, including immunomodulators and hormonal agents.
Recommended for testing:
– When planning and managing pregnancy to assess fetal infection risk.
– For diagnosing active CMV infection and therapy monitoring.
– With chronic diseases and symptoms indicating possible active infection.
– Positive result (IgM detected): indicates primary infection or virus reactivation. Monitoring, control, and if necessary antiviral therapy are required.
– Negative result (IgM absent): active infection at the time of testing is unlikely.
Important — IgM results should be interpreted together with IgG and the clinical picture to clarify infection status.
